SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Schnereger who wrote (1049)12/16/1996 8:46:00 PM
From: John H. Farro   of 4342
 
Here's a question for you all. The release on Thursday about the AndroVir study states that the subjects were not on any anti-viral medications. Presumably, at least some of those who take AndroVir when it hits the market will also be taking anti-viral drugs. How do we know that AndroVir will be safe when taken with other drugs and that there won't be any nasty side effects due to their interaction? Are they going to test for possible interaction side effects before sending AndorVir onto the market?

Robin M.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext